Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine versus bupivacaine + ondansetron wound infiltration for pain after lumbar fusion surgery
IRCT20260206068773N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of bupivacaine and ondansetron in postoperative pain (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Pain, Systolic blood pressure and 5 more. Started Apr 2026; status: completed.
02
Drugs
bupivacaineondansetron
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20260206068773N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260206068773N1.